What this means
This is a plan to enroll people and collect health information, samples, and brain scans over time. It does not show any results or whether it will lead to new treatments.
Plain-English summary written by an AI model from the registry listing.
- Status
- Recruiting
- Who can join
- Ages 60 and over · Up to 1000 adults, some with normal thinking, some with mild memory problems, and some with Alzheimer's disease
- Where
- 1 site, including Tennessee
The science
- Registered title
- Tennessee Alzheimer's Project
- Trial ID
- NCT05372172 ↗
- Phase
- Not applicable
- Study type
- observational
- Conditions
- Aging, Alzheimer Disease, Biomarker, Cognitive Dysfunction, Mild Cognitive Impairment, Dementia, Cognition
- What is tested
- none, observational study
- Sponsor
- Vanderbilt University Medical Center
- Ages
- 60 Years to no maximum
- Dates
- First posted May 12, 2022 · updated Feb 5, 2026
Registry summary
The primary objective of the Vanderbilt Alzheimer's Disease Research Center (VADRC) is to provide local and national researchers with access to a well-characterized and diverse clinical cohort, including participant referrals, biosamples, clinical data, and neuroimaging data. The VADRC Clinical Core will create an infrastructure to support research efforts of both local and national investigator studies to develop early detection, prevention, and treatment strategies for Alzheimer's disease. The Clinical Core intends to enroll up to 1000 participants, including individuals who are cognitively unimpaired, have mild cognitive impairment, or have Alzheimer's disease. This cohort of about 1000 participants will be called the Tennessee Alzheimer's Project. Participants will be seen annually for comprehensive clinical characterization and then referred to other studies to enhance Alzheimer's disease research activities.
Sites (1)
- Vanderbilt University Medical Center, Nashville, Tennessee, United States